TortsProf Blog

Editor: Christopher J. Robinette
Widener Commonwealth Law School

Wednesday, September 26, 2007

NEJM Clears (Mostly) Thimerosol

In what is a relatively uncommon event in the last few years, the New England Journal of Medicine has good news this week for pharma, or at least vaccine manufacturers.  A new study published there largely clears the the mercury in thimerosol in vaccines from causing autism:

Our study does not support a causal association between early exposure to mercury from thimerosal-containing vaccines and immune globulins and deficits in neuropsychological functioning at the age of 7 to 10 years.


Products Liability | Permalink

TrackBack URL for this entry:

Listed below are links to weblogs that reference NEJM Clears (Mostly) Thimerosol:


Post a comment